Question

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

5 comments5

Total Forecasters50

Community Prediction

(1.2% - 3%)

Make a Prediction

50%

community: 2%

No key factors yetAdd some that might influence this forecast.

Add key factor

Authors:

casens

Opened:

Nov 24, 2021

Closes:

Dec 31, 2026

Scheduled resolution:

Jan 1, 2027

Spot Scoring Time:

Nov 26, 2021

New once-a-month drug could treat diabetes and obesity, scientists say

Independent•Jun 24, 2025

Trial finds weight loss drug taken monthly helps people lose 20% of body weight

Independent•Jun 24, 2025

Experimental drug helps patients lose nearly a quarter of body weight in early trials

FOX News•Jun 24, 2025

Learn more about Metaculus NewsMatch

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

When will the FDA or EMA first approve a drug for the treatment of obesity that causes >25% weight loss?

07 Dec 2028

Authors:

casens

Opened:

Nov 24, 2021

Closes:

Dec 31, 2026

Scheduled resolution:

Jan 1, 2027

Spot Scoring Time:

Nov 26, 2021

New once-a-month drug could treat diabetes and obesity, scientists say

Independent•Jun 24, 2025

Trial finds weight loss drug taken monthly helps people lose 20% of body weight

Independent•Jun 24, 2025

Experimental drug helps patients lose nearly a quarter of body weight in early trials

FOX News•Jun 24, 2025

Learn more about Metaculus NewsMatch

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

When will the FDA or EMA first approve a drug for the treatment of obesity that causes >25% weight loss?

07 Dec 2028